From Libraries to Leads

Unlock the Therapeutic Potential of Targeted Protein Degradation

NEOsphere Biotechnologies accelerates induced proximity drug discovery with high‑throughput proteomics.

From hit identification through lead optimization, we deliver the data to power your therapeutic pipelines.

Target
degradation

ub

Target
ubiquitination

e3 ligase

Ternary complex
formation

target

Compound
binding

compound

Target degradation

ub

Target ubiquitination

E3 Ligase

Ternary complex formation

Target

Compound binding

Precise

High-throughput DIA-MS and automated data analysis deliver proteome-wide insights with exceptional accuracy and sensitivity.

Comprehensive

Maximum proteome coverage and rapid turnaround enable
in‑depth characterization of degraders, stabilizers, and proximity-inducing molecules.

Flexible

Screening across cell lines, primary cells, tissues, and patient-derived materials captures disease-relevant compound effects.

Integrated

End-to-end workflow — from cell culture and treatment through mass spectrometry to data interpretation.